InnoMedica's team lives creative thinking and innovation combined with professional competence and patient proximity.

Become part of the young team and get involved in InnoMedica's goal of giving patients access to a new generation of nano-medicines. Apply now and actively contribute to the company's success. Unsolicited applications are also welcome. We look forward to receiving your application!

Business Application Engineer

Place of work Marly near Fribourg and Bern

You are responsible for the maintenance of internal IT applications (ERP, GMP and laboratory software) and ensure their further development as well as the training and support of the users. Moreover, you are responsible for data and information management, including access control and data security. You design concepts for the expansion and extension of existing IT systems, produce internal solutions and manage external procurement projects.

Production and Process Engineer Pharma

Place of work Marly near Fribourg

As part of the Production and Engineering team you will produce pharmaceutical products
for ongoing clinical trials. In this context, you contribute significantly to the development
of new GMP production processes with the aim of increasing production capacity. You will
be responsible for ensuring and documenting the high-quality standards according to cGMP guidelines. In interdepartmental projects, you will be involved in complex matters
regarding product scaling, product stability or process automation. Further, you will be in
charge of the evaluation, purchasing and maintenance of production equipment.



Most Recent Updates

May 2022

Parkinson trial and internationalization

NEON trial: Dose escalation completed – Parkinson’s patients want to continue treatment with Talineuren. The first …

Read more

March 2022

Stéfan Halbherr and InnoMedica receive CLINAM Award

CLINAM Award 2022 for special achievements in nanomedicine for Stéfan Halbherr and InnoMedica The Scientific Committee of …

Read more

March 2022

Update Talineuren and Capital Increase 2022

First Parkinson’s patients in the NEON study treated with Talineuren On December 14, 2021, the clinical …

Read more